AT McGown

556 total citations
11 papers, 495 citations indexed

About

AT McGown is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, AT McGown has authored 11 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in AT McGown's work include Cancer therapeutics and mechanisms (3 papers), Synthesis and biological activity (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). AT McGown is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Synthesis and biological activity (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). AT McGown collaborates with scholars based in United Kingdom, United States and Ireland. AT McGown's co-authors include George R. Pettit, Julie A. Woods, John A. Hadfield, C.S. Potten, Catherine Booth, Gordon C. Jayson, J Prendiville, Christof Scheid, GR Pettit and D Crowther and has published in prestigious journals such as British Journal of Cancer, PubMed and ChemInform.

In The Last Decade

AT McGown

11 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AT McGown United Kingdom 8 236 151 141 76 62 11 495
Estelle G. McLean United Kingdom 5 271 1.1× 100 0.7× 177 1.3× 49 0.6× 65 1.0× 7 479
Shigeki Kashimoto Japan 14 339 1.4× 243 1.6× 185 1.3× 46 0.6× 53 0.9× 21 733
Jonathan J. Hollick United Kingdom 9 374 1.6× 127 0.8× 251 1.8× 31 0.4× 53 0.9× 14 703
Czesław Radzikowski Poland 14 338 1.4× 130 0.9× 99 0.7× 99 1.3× 33 0.5× 28 533
Nicole Caspers United States 15 490 2.1× 231 1.5× 113 0.8× 60 0.8× 53 0.9× 19 809
Michel Tarpin France 11 235 1.0× 83 0.5× 114 0.8× 24 0.3× 69 1.1× 18 515
Darin E. Jones United States 20 297 1.3× 373 2.5× 69 0.5× 47 0.6× 73 1.2× 44 796
Ki Deok Shin South Korea 7 404 1.7× 142 0.9× 186 1.3× 52 0.7× 64 1.0× 7 711
Marie Suggitt United Kingdom 8 201 0.9× 116 0.8× 147 1.0× 18 0.2× 65 1.0× 9 435
Mehul Patel United States 12 292 1.2× 55 0.4× 133 0.9× 28 0.4× 23 0.4× 24 513

Countries citing papers authored by AT McGown

Since Specialization
Citations

This map shows the geographic impact of AT McGown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AT McGown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AT McGown more than expected).

Fields of papers citing papers by AT McGown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AT McGown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AT McGown. The network helps show where AT McGown may publish in the future.

Co-authorship network of co-authors of AT McGown

This figure shows the co-authorship network connecting the top 25 collaborators of AT McGown. A scholar is included among the top collaborators of AT McGown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AT McGown. AT McGown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Booth, Catherine, et al.. (1999). Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. British Journal of Cancer. 80(10). 1550–1557. 79 indexed citations
2.
Booth, Catherine, et al.. (1999). Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. British Journal of Cancer. 80(10). 1550–1557. 2 indexed citations
3.
McGown, AT, et al.. (1998). Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro. British Journal of Cancer. 77(2). 216–220. 18 indexed citations
4.
Jordan, Allan M., John A. Hadfield, Nicholas J. Lawrence, & AT McGown. (1998). ChemInform Abstract: Tubulin as a Target for Anticancer Drugs: Agents which Interact with the Mitotic Spindle. ChemInform. 29(38). 7 indexed citations
5.
Searcey, Mark, et al.. (1998). Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.. PubMed. 13(8). 837–55. 30 indexed citations
6.
Woods, Julie A., et al.. (1995). The interaction with tubulin of a series of stilbenes based on combretastatin A-4. British Journal of Cancer. 71(4). 705–711. 151 indexed citations
7.
Jayson, Gordon C., D Crowther, J Prendiville, et al.. (1995). A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion. British Journal of Cancer. 72(2). 461–468. 113 indexed citations
8.
Prendiville, J, AT McGown, Andreas J. Gescher, et al.. (1994). Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1. British Journal of Cancer. 70(4). 573–578. 8 indexed citations
9.
McGown, AT, et al.. (1989). Interaction of the novel agent amphethinile with tubulin. British Journal of Cancer. 59(6). 865–868. 4 indexed citations
10.
McGown, AT, et al.. (1989). Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile.. PubMed. 3(4). 249–54. 78 indexed citations
11.
McGown, AT, et al.. (1988). Pre-clinical studies of a novel anti-mitotic agent, amphethinile. British Journal of Cancer. 57(2). 157–159. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026